December 3rd, I will be giving a webinar covering the updated guidance along with giving an overview of everything nitrosamines, including risk assessments and mitigation strategies, showing novel work from the Adare team.
Registration:
From Ambiguity to Action: The FDA’s New Nitrosamine Guidance
